After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.
788-G8) activity in the K562 human chronic myelogenous leukemia cell line. The ED50 for this effect is 0.02-0.12 µg/mL." class="big_lightbox">
788-G8) activity in the K562 human chronic myelogenous leukemia cell line. The ED50 for this effect is 0.02-0.12 µg/mL." alt="Recombinant Mouse GASP-1/WFIKKN2 (Catalog # 9956-GS) dose dependently inhibits Recombinant Human/Mouse/Rat GDF-8/Myostatin (Catalog # 788-G8) activity in the K562 human chronic myelogenous leukemia cell line. The ED50 for this effect is 0.02-0.12 µg/mL." class="big_thumb" />